Kadam Lab

Epilepsy research lab striving to find evidence based solutions for seizure management using translational research. 🇮🇳🇺🇸@KennedyKrieger @HopkinsMedicine

[Virginie McNamar @McNamarVirginie]

Thankful for Guapa, Ty’s #servicedog who took care of him during a #seizure the monitor would not pick up since there is no movement.

[Kadam Lab @KadamLab]

Working with supportive patient advocacy groups is a huge boost to challenging research undertakings that require the collection and curation of long-duration EEG recordings for NDDs. Tremendous gratitude! 🙏 @cureSYNGAP1
https://t.co/hYjw5042Ym

[Kadam Lab @KadamLab]

The lab is thrilled to host next weeks PNC seminar! @KennedyKrieger @HopkinsMedicine

[Kadam Lab @KadamLab]

Excited to develop a new summer at Hopkins course (2022) focused on brain disorders with epilepsy. @HopkinsMedicine https://t.co/gfWlkvba3O

[Ana Mingorance @CNSdrughunter]

The Burj Khalifa celebrates today's #RareDiseaseDay💙💚💜

[Anna Maria Costa @Anna_MCosta90]

@KadamLab @4EUepilepsy @IlaeWeb @yesILAE Here, we are! #4EUepilepsy #group4 #epileptogenesis It's so exciting!! 🤩🤩🤩

[Kadam Lab @KadamLab]

The @4EUepilepsy course started today with 40 international student scholars. Humbled and excited to meet them all and lead Group 4 for their group project! @IlaeWeb @yesILAE

[Prof. Akiko Iwasaki @VirusesImmunity]

We need your help for some crucial #LongCOVID research! If you live in the New York area, have FULLY recovered from COVID-19 infection and it has been AT LEAST 12 weeks since you were first sick, please email us at [email protected]  @PutrinoLab

RT highly appreciated 🙏🏼

[Kadam Lab @KadamLab]

The very first Hopkins undergrad student trainee who joined the lab as a freshman and stayed to do a masters defends his PhD thesis this week in Chicago! So proud! @JohnsHopkins @NorthwesternU

[Kadam Lab @KadamLab]

@JMGraglia @NicoleZJohnson1 @phalliburton Our paper showed a significant increase in receptors with a specific AMPA subunit GluA2. Fycoma is a pan AMPA antagonist. I believe a GluA2 specific antagonist would likely even work better for SYNGAP1 at low-doses

[Dr. Glaucomflecken @DGlaucomflecken]

It’s not about the money

[CDKL5 - IFCR @CDKL5_IFCR]

8 Centers | 200 Patients | 1 Goal
#CDKL5 clinical trial ready!
✨Will you be 1 of 200?✨

[Sam Horrell 🗿 @DrHorrell]

Who needs wordle when you've got a balance with a couple of LEDs out?

[Dr. Glaucomflecken @DGlaucomflecken]

Nature does open access

[Kadam Lab @KadamLab]

Lab papers - post-docs for the win 🏆 - give us feedback!

[CURE SYNGAP1 aka SynGAP Research Fund 501(C)(3) @cureSYNGAP1]

@CoreyBaysden @LorrieForseth @Duke_Childrens @DukeUniversity1 FYI @KadamLab 👆and @biosignals

[Jarcce @RomppainenJari]

My very first tweet ever🔥
We had unbelievable beautiful northernlights with full moon on saturday morning😍🔥
#northernlights #videography #Finland

[Kadam Lab @KadamLab]

Thank you @CureEpilepsy for highlighting our recent paper! Kennedy Krieger Researchers @KennedyKrieger Identify Potential Pathway to Improve Treatment For Newborns With Drug-Resistant Seizures: https://t.co/QnQnjD5tho

[SYNGAP1 Foundation @Syngap1Fnd]

Exciting news from @s_searchlight for #SYNGAP1 @Syngap1Fnd

New iPSC lines from Simons Searchlight participants are now available

https://t.co/bDmIuUJW5Q

[Kristin Bigos @KristinBigos]

Celebrating successes made by women in the biomedical sciences. ⁦@JohnsHopkins⁩